APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Freund Adjuvant

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Freund Adjuvant Industry Growth and Trends Forecast to 2032

Report ID 173993180129 December 2025101 pages

Choose your research edition.

Industry ResearchFreund Adjuvant Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Freund Adjuvant Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Freund Adjuvant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Freund Adjuvant Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Freund Adjuvant Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Freund Adjuvant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Freund Adjuvant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Freund Adjuvant is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Freund Adjuvant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Freund Adjuvant include Shanghai Maokang Biotechnology, DIYIBio, Beyotime, Wako Pure Chemical Industries, Thermo Scientific, Sigma Aldrich, Rockland Immunochemicals, MP Biomedicals and InvivoGen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Freund Adjuvant market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Freund Adjuvant market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Freund Adjuvant market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Freund Adjuvant.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Freund Adjuvant market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Freund Adjuvant Market by Company

Shanghai Maokang Biotechnology

DIYIBio

Beyotime

Wako Pure Chemical Industries

Thermo Scientific

Sigma Aldrich

Rockland Immunochemicals

MP Biomedicals

InvivoGen

Creative Diagnostics

Advanced Biomart

Freund Adjuvant Segment by Type

Freunds Complete Adjuvant (FCA)

Freunds Incomplete Adjuvant (FICA)

Freund Adjuvant Segment by Application

Medicine

Scientific Research

Freund Adjuvant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Freund Adjuvant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Freund Adjuvant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Freund Adjuvant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Freund Adjuvant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Freund Adjuvant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Freunds Complete Adjuvant (FCA) Table 2. Major Company of Freunds Incomplete Adjuvant (FICA) Table 3. Global Freund Adjuvant Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Freund Adjuvant Sales by Type (2021-2026) & (Tons) Table 5. Global Freund Adjuvant Sales Market Share in Volume by Type (2021-2026) Table 6. Global Freund Adjuvant Sales by Type (2021-2026) & (US$ Million) Table 7. Global Freund Adjuvant Sales Market Share in Value by Type (2021-2026) Table 8. Global Freund Adjuvant Price by Type (2021-2026) & (US$/Kg) Table 9. Global Freund Adjuvant Sales by Type (2027-2032) & (Tons) Table 10. Global Freund Adjuvant Sales Market Share in Volume by Type (2027-2032) Table 11. Global Freund Adjuvant Sales by Type (2027-2032) & (US$ Million) Table 12. Global Freund Adjuvant Sales Market Share in Value by Type (2027-2032) Table 13. Global Freund Adjuvant Price by Type (2027-2032) & (US$/Kg) Table 14. North America Freund Adjuvant Sales by Type (2021-2026) & (Tons) Table 15. North America Freund Adjuvant Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Freund Adjuvant Sales by Type (2021-2026) & (Tons) Table 17. Europe Freund Adjuvant Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Freund Adjuvant Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Freund Adjuvant Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Freund Adjuvant Sales by Type (2021-2026) & (Tons) Table 21. Latin America Freund Adjuvant Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Freund Adjuvant Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Freund Adjuvant Sales by Type (2021-2026) & (US$ Million) Table 24. Freund Adjuvant Industry Trends Table 25. Freund Adjuvant Industry Drivers Table 26. Freund Adjuvant Industry Opportunities and Challenges Table 27. Freund Adjuvant Industry Restraints Table 28. Global Freund Adjuvant Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Freund Adjuvant Revenue Market Share by Company (2021-2026) Table 30. Global Freund Adjuvant Sales by Company (2021-2026) & (Tons) Table 31. Global Freund Adjuvant Sales Share by Company (2021-2026) Table 32. Global Freund Adjuvant Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Freund Adjuvant Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Freund Adjuvant Major Company Production Sites and Headquarters Table 35. Global Freund Adjuvant Company, Product Type & Application Table 36. Global Freund Adjuvant Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Freund Adjuvant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Freund Adjuvant Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Freund Adjuvant Sales by Region (2021-2026) & (Tons) Table 41. Global Freund Adjuvant Sales Market Share in Volume by Region (2021-2026) Table 42. Global Freund Adjuvant Sales by Region (2021-2026) & (US$ Million) Table 43. Global Freund Adjuvant Sales Market Share in Value by Region (2021-2026) Table 44. Global Freund Adjuvant Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Freund Adjuvant Sales by Region (2027-2032) & (Tons) Table 46. Global Freund Adjuvant Sales Market Share in Volume by Region (2027-2032) Table 47. Global Freund Adjuvant Sales by Region (2027-2032) & (US$ Million) Table 48. Global Freund Adjuvant Sales Market Share in Value by Region (2027-2032) Table 49. Global Freund Adjuvant Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Freund Adjuvant Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Freund Adjuvant Sales by Application (2021-2026) & (Tons) Table 52. Global Freund Adjuvant Sales Market Share in Volume by Application (2021-2026) Table 53. Global Freund Adjuvant Sales by Application (2021-2026) & (US$ Million) Table 54. Global Freund Adjuvant Sales Market Share in Value by Application (2021-2026) Table 55. Global Freund Adjuvant Price by Application (2021-2026) & (US$/Kg) Table 56. Global Freund Adjuvant Sales by Application (2027-2032) & (Tons) Table 57. Global Freund Adjuvant Sales Market Share in Volume by Application (2027-2032) Table 58. Global Freund Adjuvant Sales by Application (2027-2032) & (US$ Million) Table 59. Global Freund Adjuvant Sales Market Share in Value by Application (2027-2032) Table 60. Global Freund Adjuvant Price by Application (2027-2032) & (US$/Kg) Table 61. North America Freund Adjuvant Sales by Application (2021-2026) & (Tons) Table 62. North America Freund Adjuvant Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Freund Adjuvant Sales by Application (2021-2026) & (Tons) Table 64. Europe Freund Adjuvant Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Freund Adjuvant Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Freund Adjuvant Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Freund Adjuvant Sales by Application (2021-2026) & (Tons) Table 68. Latin America Freund Adjuvant Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Freund Adjuvant Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Freund Adjuvant Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Maokang Biotechnology Company Information Table 72. Shanghai Maokang Biotechnology Business Overview Table 73. Shanghai Maokang Biotechnology Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Shanghai Maokang Biotechnology Freund Adjuvant Product Portfolio Table 75. Shanghai Maokang Biotechnology Recent Development Table 76. DIYIBio Company Information Table 77. DIYIBio Business Overview Table 78. DIYIBio Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. DIYIBio Freund Adjuvant Product Portfolio Table 80. DIYIBio Recent Development Table 81. Beyotime Company Information Table 82. Beyotime Business Overview Table 83. Beyotime Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Beyotime Freund Adjuvant Product Portfolio Table 85. Beyotime Recent Development Table 86. Wako Pure Chemical Industries Company Information Table 87. Wako Pure Chemical Industries Business Overview Table 88. Wako Pure Chemical Industries Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Wako Pure Chemical Industries Freund Adjuvant Product Portfolio Table 90. Wako Pure Chemical Industries Recent Development Table 91. Thermo Scientific Company Information Table 92. Thermo Scientific Business Overview Table 93. Thermo Scientific Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Thermo Scientific Freund Adjuvant Product Portfolio Table 95. Thermo Scientific Recent Development Table 96. Sigma Aldrich Company Information Table 97. Sigma Aldrich Business Overview Table 98. Sigma Aldrich Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Sigma Aldrich Freund Adjuvant Product Portfolio Table 100. Sigma Aldrich Recent Development Table 101. Rockland Immunochemicals Company Information Table 102. Rockland Immunochemicals Business Overview Table 103. Rockland Immunochemicals Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Rockland Immunochemicals Freund Adjuvant Product Portfolio Table 105. Rockland Immunochemicals Recent Development Table 106. MP Biomedicals Company Information Table 107. MP Biomedicals Business Overview Table 108. MP Biomedicals Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. MP Biomedicals Freund Adjuvant Product Portfolio Table 110. MP Biomedicals Recent Development Table 111. InvivoGen Company Information Table 112. InvivoGen Business Overview Table 113. InvivoGen Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. InvivoGen Freund Adjuvant Product Portfolio Table 115. InvivoGen Recent Development Table 116. Creative Diagnostics Company Information Table 117. Creative Diagnostics Business Overview Table 118. Creative Diagnostics Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Creative Diagnostics Freund Adjuvant Product Portfolio Table 120. Creative Diagnostics Recent Development Table 121. Advanced Biomart Company Information Table 122. Advanced Biomart Business Overview Table 123. Advanced Biomart Freund Adjuvant Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Advanced Biomart Freund Adjuvant Product Portfolio Table 125. Advanced Biomart Recent Development Table 126. North America Freund Adjuvant Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 127. North America Freund Adjuvant Sales by Country (2021-2026) & (Tons) Table 128. North America Freund Adjuvant Sales Market Share by Country (2021-2026) Table 129. North America Freund Adjuvant Sales Forecast by Country (2027-2032) & (Tons) Table 130. North America Freund Adjuvant Sales Market Share Forecast by Country (2027-2032) Table 131. North America Freund Adjuvant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Freund Adjuvant Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Freund Adjuvant Market Share by Country (2021-2026) Table 134. North America Freund Adjuvant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Freund Adjuvant Market Share Forecast by Country (2027-2032) Table 136. Europe Freund Adjuvant Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 137. Europe Freund Adjuvant Sales by Country (2021-2026) & (Tons) Table 138. Europe Freund Adjuvant Sales Market Share by Country (2021-2026) Table 139. Europe Freund Adjuvant Sales Forecast by Country (2027-2032) & (Tons) Table 140. Europe Freund Adjuvant Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Freund Adjuvant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Freund Adjuvant Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Freund Adjuvant Market Share by Country (2021-2026) Table 144. Europe Freund Adjuvant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Freund Adjuvant Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Freund Adjuvant Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Freund Adjuvant Sales by Country (2021-2026) & (Tons) Table 148. Asia-Pacific Freund Adjuvant Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Freund Adjuvant Sales Forecast by Country (2027-2032) & (Tons) Table 150. Asia-Pacific Freund Adjuvant Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Freund Adjuvant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Freund Adjuvant Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Freund Adjuvant Market Share by Country (2021-2026) Table 154. Asia-Pacific Freund Adjuvant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Freund Adjuvant Market Share Forecast by Country (2027-2032) Table 156. Latin America Freund Adjuvant Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 157. Latin America Freund Adjuvant Sales by Country (2021-2026) & (Tons) Table 158. Latin America Freund Adjuvant Sales Market Share by Country (2021-2026) Table 159. Latin America Freund Adjuvant Sales Forecast by Country (2027-2032) & (Tons) Table 160. Latin America Freund Adjuvant Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Freund Adjuvant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Freund Adjuvant Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Freund Adjuvant Market Share by Country (2021-2026) Table 164. Latin America Freund Adjuvant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Freund Adjuvant Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Freund Adjuvant Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Freund Adjuvant Sales by Country (2021-2026) & (Tons) Table 168. Middle East and Africa Freund Adjuvant Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Freund Adjuvant Sales Forecast by Country (2027-2032) & (Tons) Table 170. Middle East and Africa Freund Adjuvant Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Freund Adjuvant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Freund Adjuvant Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Freund Adjuvant Market Share by Country (2021-2026) Table 174. Middle East and Africa Freund Adjuvant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Freund Adjuvant Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Freund Adjuvant Distributors List Table 179. Freund Adjuvant Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Freund Adjuvant Image Figure 2. Global Freund Adjuvant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Freund Adjuvant Market Size (2021-2032) & (US$ Million) Figure 4. Global Freund Adjuvant Sales (2021-2032) & (Tons) Figure 5. Freunds Complete Adjuvant (FCA) Image Figure 6. Global Freunds Complete Adjuvant (FCA) Sales YoY Growth (2021-2032) & (Tons) Figure 7. Freunds Incomplete Adjuvant (FICA) Image Figure 8. Global Freunds Incomplete Adjuvant (FICA) Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Freund Adjuvant Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Freund Adjuvant Market Share by Type 2025 VS 2032 Figure 11. North America Freund Adjuvant Sales Market Share in Volume by Type in 2025 Figure 12. North America Freund Adjuvant Sales Market Share in Value by Type in 2025 Figure 13. Europe Freund Adjuvant Sales Market Share in Volume by Type in 2025 Figure 14. Europe Freund Adjuvant Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Freund Adjuvant Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Freund Adjuvant Sales Market Share in Value by Type in 2025 Figure 17. Latin America Freund Adjuvant Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Freund Adjuvant Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Freund Adjuvant Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Freund Adjuvant Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Freund Adjuvant Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medicine Image Figure 24. Global Medicine Sales YoY Growth (2021-2032) & (Tons) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Freund Adjuvant Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Freund Adjuvant Market Share by Application 2025 VS 2032 Figure 29. North America Freund Adjuvant Sales Market Share in Volume by Application in 2025 Figure 30. North America Freund Adjuvant Sales Market Share in Value by Application in 2025 Figure 31. Europe Freund Adjuvant Sales Market Share in Volume by Application in 2025 Figure 32. Europe Freund Adjuvant Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Freund Adjuvant Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Freund Adjuvant Sales Market Share in Value by Application in 2025 Figure 35. Latin America Freund Adjuvant Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Freund Adjuvant Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Freund Adjuvant Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Freund Adjuvant Sales Market Share in Value by Application in 2025 Figure 39. North America Freund Adjuvant Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Freund Adjuvant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Freund Adjuvant Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Freund Adjuvant Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Freund Adjuvant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Freund Adjuvant Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Freund Adjuvant Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Freund Adjuvant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Freund Adjuvant Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Freund Adjuvant Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Freund Adjuvant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Freund Adjuvant Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Freund Adjuvant Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Freund Adjuvant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Freund Adjuvant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Freund Adjuvant Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Freund Adjuvant Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Freund Adjuvant Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Freunds Complete Adjuvant (FCA)
  • Freunds Incomplete Adjuvant (FICA)
Applications
  • Medicine
  • Scientific Research
Companies covered
  • Shanghai Maokang Biotechnology
  • DIYIBio
  • Beyotime
  • Wako Pure Chemical Industries
  • Thermo Scientific
  • Sigma Aldrich
  • Rockland Immunochemicals
  • MP Biomedicals
  • InvivoGen
  • Creative Diagnostics
  • Advanced Biomart

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Freund Adjuvant Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Freund Adjuvant Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Freund Adjuvant Market by Type
  6. 1.3.1 Freunds Complete Adjuvant (FCA)
  7. 1.3.2 Freunds Incomplete Adjuvant (FICA)
  8. 1.4 Global Freund Adjuvant Market Size by Type
  9. 1.4.1 Global Freund Adjuvant Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Freund Adjuvant Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Freund Adjuvant Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Freund Adjuvant Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Freund Adjuvant Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Freund Adjuvant Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Freund Adjuvant Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Freund Adjuvant Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Freund Adjuvant Industry Trends
  2. 2.2 Freund Adjuvant Industry Drivers
  3. 2.3 Freund Adjuvant Industry Opportunities and Challenges
  4. 2.4 Freund Adjuvant Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Freund Adjuvant Revenue (2021-2026)
  2. 3.2 Global Top Players by Freund Adjuvant Sales (2021-2026)
  3. 3.3 Global Top Players by Freund Adjuvant Price (2021-2026)
  4. 3.4 Global Freund Adjuvant Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Freund Adjuvant Major Company Production Sites & Headquarters
  6. 3.6 Global Freund Adjuvant Company, Product Type & Application
  7. 3.7 Global Freund Adjuvant Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Freund Adjuvant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Freund Adjuvant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Freund Adjuvant Tier 1, Tier 2, and Tier 3
4 Freund Adjuvant Regional Status and Outlook
  1. 4.1 Global Freund Adjuvant Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Freund Adjuvant Historic Market Size by Region
  3. 4.2.1 Global Freund Adjuvant Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Freund Adjuvant Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Freund Adjuvant Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Freund Adjuvant Forecasted Market Size by Region
  7. 4.3.1 Global Freund Adjuvant Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Freund Adjuvant Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Freund Adjuvant Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Freund Adjuvant by Application
  1. 5.1 Freund Adjuvant Market by Application
  2. 5.1.1 Medicine
  3. 5.1.2 Scientific Research
  4. 5.2 Global Freund Adjuvant Market Size by Application
  5. 5.2.1 Global Freund Adjuvant Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Freund Adjuvant Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Freund Adjuvant Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Freund Adjuvant Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Freund Adjuvant Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Freund Adjuvant Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Freund Adjuvant Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Freund Adjuvant Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Maokang Biotechnology
  2. 6.1.1 Shanghai Maokang Biotechnology Company Information
  3. 6.1.2 Shanghai Maokang Biotechnology Business Overview
  4. 6.1.3 Shanghai Maokang Biotechnology Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Maokang Biotechnology Freund Adjuvant Product Portfolio
  6. 6.1.5 Shanghai Maokang Biotechnology Recent Developments
  7. 6.2 DIYIBio
  8. 6.2.1 DIYIBio Company Information
  9. 6.2.2 DIYIBio Business Overview
  10. 6.2.3 DIYIBio Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DIYIBio Freund Adjuvant Product Portfolio
  12. 6.2.5 DIYIBio Recent Developments
  13. 6.3 Beyotime
  14. 6.3.1 Beyotime Company Information
  15. 6.3.2 Beyotime Business Overview
  16. 6.3.3 Beyotime Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Beyotime Freund Adjuvant Product Portfolio
  18. 6.3.5 Beyotime Recent Developments
  19. 6.4 Wako Pure Chemical Industries
  20. 6.4.1 Wako Pure Chemical Industries Company Information
  21. 6.4.2 Wako Pure Chemical Industries Business Overview
  22. 6.4.3 Wako Pure Chemical Industries Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wako Pure Chemical Industries Freund Adjuvant Product Portfolio
  24. 6.4.5 Wako Pure Chemical Industries Recent Developments
  25. 6.5 Thermo Scientific
  26. 6.5.1 Thermo Scientific Company Information
  27. 6.5.2 Thermo Scientific Business Overview
  28. 6.5.3 Thermo Scientific Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Scientific Freund Adjuvant Product Portfolio
  30. 6.5.5 Thermo Scientific Recent Developments
  31. 6.6 Sigma Aldrich
  32. 6.6.1 Sigma Aldrich Company Information
  33. 6.6.2 Sigma Aldrich Business Overview
  34. 6.6.3 Sigma Aldrich Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sigma Aldrich Freund Adjuvant Product Portfolio
  36. 6.6.5 Sigma Aldrich Recent Developments
  37. 6.7 Rockland Immunochemicals
  38. 6.7.1 Rockland Immunochemicals Company Information
  39. 6.7.2 Rockland Immunochemicals Business Overview
  40. 6.7.3 Rockland Immunochemicals Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Rockland Immunochemicals Freund Adjuvant Product Portfolio
  42. 6.7.5 Rockland Immunochemicals Recent Developments
  43. 6.8 MP Biomedicals
  44. 6.8.1 MP Biomedicals Company Information
  45. 6.8.2 MP Biomedicals Business Overview
  46. 6.8.3 MP Biomedicals Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MP Biomedicals Freund Adjuvant Product Portfolio
  48. 6.8.5 MP Biomedicals Recent Developments
  49. 6.9 InvivoGen
  50. 6.9.1 InvivoGen Company Information
  51. 6.9.2 InvivoGen Business Overview
  52. 6.9.3 InvivoGen Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 InvivoGen Freund Adjuvant Product Portfolio
  54. 6.9.5 InvivoGen Recent Developments
  55. 6.10 Creative Diagnostics
  56. 6.10.1 Creative Diagnostics Company Information
  57. 6.10.2 Creative Diagnostics Business Overview
  58. 6.10.3 Creative Diagnostics Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Creative Diagnostics Freund Adjuvant Product Portfolio
  60. 6.10.5 Creative Diagnostics Recent Developments
  61. 6.11 Advanced Biomart
  62. 6.11.1 Advanced Biomart Company Information
  63. 6.11.2 Advanced Biomart Business Overview
  64. 6.11.3 Advanced Biomart Freund Adjuvant Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Advanced Biomart Freund Adjuvant Product Portfolio
  66. 6.11.5 Advanced Biomart Recent Developments
7 North America by Country
  1. 7.1 North America Freund Adjuvant Sales by Country
  2. 7.1.1 North America Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Freund Adjuvant Sales by Country (2021-2026)
  4. 7.1.3 North America Freund Adjuvant Sales Forecast by Country (2027-2032)
  5. 7.2 North America Freund Adjuvant Market Size by Country
  6. 7.2.1 North America Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Freund Adjuvant Market Size by Country (2021-2026)
  8. 7.2.3 North America Freund Adjuvant Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Freund Adjuvant Sales by Country
  2. 8.1.1 Europe Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Freund Adjuvant Sales by Country (2021-2026)
  4. 8.1.3 Europe Freund Adjuvant Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Freund Adjuvant Market Size by Country
  6. 8.2.1 Europe Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Freund Adjuvant Market Size by Country (2021-2026)
  8. 8.2.3 Europe Freund Adjuvant Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Freund Adjuvant Sales by Country
  2. 9.1.1 Asia-Pacific Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Freund Adjuvant Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Freund Adjuvant Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Freund Adjuvant Market Size by Country
  6. 9.2.1 Asia-Pacific Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Freund Adjuvant Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Freund Adjuvant Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Freund Adjuvant Sales by Country
  2. 10.1.1 South America Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Freund Adjuvant Sales by Country (2021-2026)
  4. 10.1.3 South America Freund Adjuvant Sales Forecast by Country (2027-2032)
  5. 10.2 South America Freund Adjuvant Market Size by Country
  6. 10.2.1 South America Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Freund Adjuvant Market Size by Country (2021-2026)
  8. 10.2.3 South America Freund Adjuvant Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Freund Adjuvant Sales by Country
  2. 11.1.1 Middle East and Africa Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Freund Adjuvant Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Freund Adjuvant Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Freund Adjuvant Market Size by Country
  6. 11.2.1 Middle East and Africa Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Freund Adjuvant Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Freund Adjuvant Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Freund Adjuvant Value Chain Analysis
  2. 12.1.1 Freund Adjuvant Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Freund Adjuvant Production Mode & Process
  7. 12.2 Freund Adjuvant Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Freund Adjuvant Distributors
  10. 12.2.3 Freund Adjuvant Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst